IntelliSyn was founded by Jeffrey Albert in 2011 to bring together outstanding pharma researchers in the Montreal area following the closure of major sites by AstraZeneca, Boehringer Ingelheim, and Merck Frosst.
Within these companies, our team members worked with scientific CROs from all across the world and came to understand the frequent challenges and frustrations with these CROs. IntelliSyn was formed to bring highly efficient capabilities and experienced personnel to rapidly advance client’s projects on a reliable, secure, and economical basis.
Jeffrey Albert, Ph.D. Founder and Director
Jeff is IntelliSyn’s Founder and Director. Over 20 years’ experience in Medicinal Chemistry at AstraZeneca at the US and in Canada. He served as Section Head in the Lead Discovery Department and as Project Leader in the Neuroscience Department. His teams have successfully delivered 4 drugs into clinical development, two of which are currently in Ph-3. He has authored or co-authored >50 publications, >45 patents, 5 book chapters, and one book.
Shawn Johnstone, Ph.D. Director of Chemistry
Shawn has 18 years’ experience in major pharma. Formerly, he was at AstraZeneca and served as Project Lead for multiple projects across CNS disease and pain disorders, resulting in 3 drugs entering clinical trials. He has specialized drug development experience in GPCR and ion channel targets, particularly involving NAMs, PAMs, and biased signaling agents. He holds a PhD in synthetic chemistry from University of Montreal and an MSc in organometallic chemistry from University of Toronto.
MICHAEL COVENS, CFO
Michael has over 35 years of experience as a financial executive, key member of the senior management team and partner in a midsized accounting firm. He is a Chartered Accountant (CPA, CA) and holds a Bachelor of Commerce from Concordia University and a Diploma in Public Accountancy from McGill University.
Michael has over 14 years of experience as a senior executive and CFO for a large private specialty fashion retailer with locations throughout Canada. His operational responsibilities beyond accounting and finance included inventory management, information technology, human resources, loss prevention, lease negotiation, and store construction.
you can trust
IntelliSyn delivers excellence, innovation, and efficiency.
More than 75% of our scientists have Ph.D. degrees and post-doctoral work at leading Universities in the US, Canada, or Europe.
Our lead scientists have 15-25 years of experience within major pharma, including AstraZeneca, Boehringer Ingelheim, and Merck.